These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 22530665)

  • 1. Cytosine arabinoside potentiates the apoptotic effect of bendamustine on several B- and T-cell leukemia/lymphoma cells and cell lines.
    Castegnaro S; Visco C; Chieregato K; Bernardi M; Albiero E; Zanon C; Madeo D; Rodeghiero F
    Leuk Lymphoma; 2012 Nov; 53(11):2262-8. PubMed ID: 22530665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cytotoxic effects of bendamustine in combination with cytarabine in mantle cell lymphoma cell lines.
    Visco C; Castegnaro S; Chieregato K; Bernardi M; Albiero E; Zanon C; Madeo D; Rodeghiero F
    Blood Cells Mol Dis; 2012 Jan; 48(1):68-75. PubMed ID: 22036761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro induction of apoptosis of neoplastic cells in low-grade non-Hodgkin's lymphomas using combinations of established cytotoxic drugs with bendamustine.
    Chow KU; Boehrer S; Geduldig K; Krapohl A; Hoelzer D; Mitrou PS; Weidmann E
    Haematologica; 2001 May; 86(5):485-93. PubMed ID: 11410411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of drug synergism between the tyrosine kinase inhibitors NSC 680410 (adaphostin) and/or STI571 (imatinib mesylate, Gleevec) with cytotoxic drugs against human leukemia cell lines.
    Avramis IA; Laug WE; Sausville EA; Avramis VI
    Cancer Chemother Pharmacol; 2003 Oct; 52(4):307-18. PubMed ID: 12827297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purine analog-like properties of bendamustine underlie rapid activation of DNA damage response and synergistic effects with pyrimidine analogues in lymphoid malignancies.
    Hiraoka N; Kikuchi J; Yamauchi T; Koyama D; Wada T; Uesawa M; Akutsu M; Mori S; Nakamura Y; Ueda T; Kano Y; Furukawa Y
    PLoS One; 2014; 9(3):e90675. PubMed ID: 24626203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bendamustine for the treatment of chronic lymphocytic leukemia and rituximab-refractory, indolent B-cell non-Hodgkin lymphoma.
    Dennie TW; Kolesar JM
    Clin Ther; 2009; 31 Pt 2():2290-311. PubMed ID: 20110042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bendamustine is effective in p53-deficient B-cell neoplasms and requires oxidative stress and caspase-independent signaling.
    Roué G; López-Guerra M; Milpied P; Pérez-Galán P; Villamor N; Montserrat E; Campo E; Colomer D
    Clin Cancer Res; 2008 Nov; 14(21):6907-15. PubMed ID: 18980985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of Pim kinase inhibitor SGI-1776 and bendamustine in B-cell lymphoma.
    Yang Q; Chen LS; Neelapu SS; Gandhi V
    Clin Lymphoma Myeloma Leuk; 2013 Sep; 13 Suppl 2(0 2):S355-62. PubMed ID: 24290221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of cytosine arabinoside (ara-C) resistance by the synergistic combination of 6-thioguanine plus ara-C plus PEG-asparaginase (TGAP) in human leukemia lines lacking or expressing p53 protein.
    Fu CH; Martin-Aragon S; Weinberg KI; Ardi VC; Danenberg PV; Avramis VI
    Cancer Chemother Pharmacol; 2001 Aug; 48(2):123-33. PubMed ID: 11561778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The combination effects of bendamustine with antimetabolites against childhood acute lymphoblastic leukemia cells.
    Goto S; Goto H; Yokosuka T
    Int J Hematol; 2016 May; 103(5):572-83. PubMed ID: 26886449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal human organic anion transporter 3 increases the susceptibility of lymphoma cells to bendamustine uptake.
    Hagos Y; Hundertmark P; Shnitsar V; Marada VV; Wulf G; Burckhardt G
    Am J Physiol Renal Physiol; 2015 Feb; 308(4):F330-8. PubMed ID: 25477469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro evaluation of bendamustine induced apoptosis in B-chronic lymphocytic leukemia.
    Schwänen C; Hecker T; Hübinger G; Wölfle M; Rittgen W; Bergmann L; Karakas T
    Leukemia; 2002 Oct; 16(10):2096-105. PubMed ID: 12357363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bendamustine hydrochloride in patients with B-cell malignancies who have comorbidities - is there an optimal dose?
    Gordon MJ; Lewis LD; Brown JR; Danilov AV
    Expert Rev Hematol; 2017 Aug; 10(8):707-718. PubMed ID: 28664772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-CD20 antibody (IDEC-C2B8, rituximab) enhances efficacy of cytotoxic drugs on neoplastic lymphocytes in vitro: role of cytokines, complement, and caspases.
    Chow KU; Sommerlad WD; Boehrer S; Schneider B; Seipelt G; Rummel MJ; Hoelzer D; Mitrou PS; Weidmann E
    Haematologica; 2002 Jan; 87(1):33-43. PubMed ID: 11801463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic Effect of Venetoclax and Bendamustine in Early T-cell Precursor Acute Lymphoblastic Leukemia.
    Nguyen HDT; LE TM; Lee D; Cho HJ; Lee J; Sohn SK; Kim JG; Ham JY; Moon JH; Han HS; Kim J; Baek DW
    In Vivo; 2024; 38(4):1740-1749. PubMed ID: 38936885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bendamustine for the treatment of indolent non-Hodgkin's lymphoma and chronic lymphocytic leukemia.
    Elefante A; Czuczman MS
    Am J Health Syst Pharm; 2010 May; 67(9):713-23. PubMed ID: 20410545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility to cytosine arabinoside (Ara-C)-induced cytotoxicity in human leukemia cell lines.
    Kanno S; Higurashi A; Watanabe Y; Shouji A; Asou K; Ishikawa M
    Toxicol Lett; 2004 Sep; 152(2):149-58. PubMed ID: 15302096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic evaluation and therapeutic activity of bendamustine in B-cell lymphoid malignancies.
    Korycka-Wołowiec A; Robak T
    Expert Opin Drug Metab Toxicol; 2012 Nov; 8(11):1455-68. PubMed ID: 22970741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bendamustine: something old, something new.
    Tageja N; Nagi J
    Cancer Chemother Pharmacol; 2010 Aug; 66(3):413-23. PubMed ID: 20376452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bendamustine's emerging role in the management of lymphoid malignancies.
    Rummel MJ; Gregory SA
    Semin Hematol; 2011 Apr; 48 Suppl 1():S24-36. PubMed ID: 21530769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.